openPR Logo
Press release

GervanoRA Added Inflammatory Bowel Disease Pipeline Analysis - 2018 Report to its Report Store

07-24-2018 09:17 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: www.gervanora.com

GervanoRA Added Inflammatory Bowel Disease Pipeline Analysis -

GervanoRA Data Services has released its latest pipeline analysis report, “Inflammatory Bowel Disease Analysis (IBD) - 2018”. The report includes complete analysis of the pipeline molecules under development used for the treatment of IBD. Report helps emerging companies to understand the strong competitor strategies through its key company profiles and SWOT analysis. Elaborated report information assist clients in understanding the current scenarios in drug development and help in development and design pipeline based in-licensing and out-licensing strategies. The Universities and Institutes added to the report are expected to play a vital role in the market growth. Apart from this, the discontinued and dormant projects poise clarity for the clients.
Required free sample report (PDF)?

https://www.gervanora.com/request-for-sample-report/

IBD Overview
IBD is a collective term for two disease conditions – Crohn’s disease and Ulcerative Colitis. It is caused by a dysregulation of the immune system inducing the production of proinflammatory cytokines and adhesion molecules. This results in the chronic inflammation of the gastrointestinal (GI) tract. Prolonged inflammation results in damage to the GI tract and may lead to ulceration, abscesses and strictures in the bowel.
Report Highlights,
 We expect that the IBD population in the US will grow from 3.1 million in 2016 to 7.9 million in 2025 at a growth rate of 11%.
 There are total 203 molecules in pipeline (Company Molecules 180, University & Institute Molecules 23) in different phases of development.
 According to GervanoRA’s analytics, there were around 99 deals happened since 2010. Among these, there are two mergers, five acquisitions, 47 collaboration agreements, 41 licensing agreements, 3 alliance agreements and four termination agreements.
 As per GervanoRA’s timeline estimations, nine drug candidates are expected to receive approvals in the coming two years. 4 drug candidates will receive regulatory approvals in the year 2019 and five will receive in the year 2020.
Report Coverage:
 Key Pipeline Events
 Drug Pipeline Analysis by Stage of Development, Geography, RoA, MoA, Drug Class, and Drug developments by Companies, Universities and Institutes.
 Disease Overview
 Epidemiology and Epidemiology Forecast
 Deals Activities
 Total Drug Approvals for the Treatment of therapeutics (From 2010)
 Estimated Drug Approval Timelines for all Pipeline Drugs
 Clinical Trials Summary
 Terminated and Discontinued Drugs Projects
 Current and Future Competitive Landscape of Companies
 Key Companies with Drug Profiles and Drug Milestones
 Key Companies SWOT Analysis
 Emerging Companies with Profiles
 Universities and Institutes with Drugs in Pipeline

About GervanoRA
GervanoRA Data Services LLP is a premier provider of syndicated research reports, custom research reports and consulting services, based in Goa, India. GDS aims to deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial views of the competitive framework, and future market trends.
At GervanoRA Data Services, we're playing our part to help clients stay ahead of the curve. We collaboratively work with a wide range of organizations (KOLs) to garner valuable key insights.
For more details, please visit our website: www.gervanora.com
Connect with us on LinkedIn @ https://in.linkedin.com/company/gervanora-data-services-llp

GervanoRA Data Services LLP is a premier provider of syndicated research reports, custom research reports and consulting services, based in Goa, India. GDS aims to deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial views of the competitive framework, and future market trends.
At GervanoRA Data Services, we're playing our part to help clients stay ahead of the curve. We collaboratively work with a wide range of organizations (KOLs) to garner valuable key insights.

GervanoRA Data Services LLP
Goa IT Innovation Center
Goa Chamber of Commerce and Industry Bldg.
South Goa, Goa
INDIA
403722.

India (Head Office)
Mr. Ramu Jadhav
GervanoRA Data
Services LLP
Verna, Goa - 403722
India
sales@gervanora.com
Ph. No. +91(0)832-2783283

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release GervanoRA Added Inflammatory Bowel Disease Pipeline Analysis - 2018 Report to its Report Store here

News-ID: 1141218 • Views: 890

More Releases for GervanoRA

GervanoRA Announced the Release of Opportunity Assessment Report Titled “Adjuv …
GervanoRA Data Services (GDS), a premier provider of market research analysis and services based in Goa, India has announced the release of their latest report on Adjuvant Metastatic Melanoma Pipeline Drugs – Opportunity Assessments, Epidemiology Forecast, Market Dynamics, and Pipeline Analysis H2 2018. GervanoRA’s pipeline analysis and opportunity assessment report “Adjuvant Metastatic Melanoma: Opportunity Assessments, Epidemiology Forecast, Market Dynamics and Pipeline Analysis, H2 2018” analyzed and assessed Adjuvant Metastatic Melanoma pipeline
GervanoRA Announced the Release of Opportunity Assessment Report Titled “Chron …
GervanoRA Data Services (GDS), a premier provider of market research analysis and services based in Goa, India has announced the release of their latest report on Chronic Lower Back Pain Pipeline Drugs – Opportunity Assessments, Epidemiology Forecast, Market Dynamics, and Pipeline Analysis H2 2018. GervanoRA’s pipeline analysis and opportunity assessment report “Chronic Lower Back Pain: Opportunity Assessments, Epidemiology Forecast, Market Dynamics and Pipeline Analysis, H2 2018” analyzed and assessed Chronic Lower
GervanoRA Announced the Release of Opportunity Assessment Report Titled “Vascu …
GervanoRA Data Services (GDS), a premier provider of market research analysis and services based in Goa, India has announced the release of their latest report on Vasculitis Pipeline Drugs – Opportunity Assessments, Epidemiology Forecast, Market Dynamics, and Pipeline Analysis H2 2018. GervanoRA’s pipeline analysis and opportunity assessment report “Vasculitis: Opportunity Assessments, Epidemiology Forecast, Market Dynamics and Pipeline Analysis, H2 2018” analyzed and assessed Vasculitis pipeline molecules for the opportunities in the
GervanoRA Announced the Release of Opportunity Assessment Report Titled “Syste …
GervanoRA Data Services (GDS), a premier provider of market research analysis and services based in Goa, India has announced the release of their latest report on Systemic Lupus Erythematosus (SLE) Pipeline Drugs – Opportunity Assessments, Epidemiology Forecast, Market Dynamics, and Pipeline Analysis H2 2018. GervanoRA’s pipeline analysis and opportunity assessment report “Systemic Lupus Erythematosus (SLE) : Opportunity Assessments, Epidemiology Forecast, Market Dynamics and Pipeline Analysis, H2 2018” analyzed and assessed Systemic
GervanoRA Announced the Release of Opportunity Assessment Report Titled “Graft …
GervanoRA Data Services (GDS) is a premier provider of market research analysis and services based in Goa, India has announced the release of their latest report on Graft versus Host Disease (GvHD) Pipeline Drugs – Opportunity Assessments, Epidemiology Forecast, Market Dynamics, and Pipeline Analysis H2 2018. GervanoRA analyzed and assessed Graft versus Host Disease (GvHD) pipeline molecules for the opportunities in the competitive space by covering all the pipeline molecules in
GervanoRA Announced the Release of Opportunity Assessment Report Titled “Ankyl …
GervanoRA Data Services (GDS) is a premier provider of market research analysis and services based in Goa, India has announced the release of their latest report on Ankylosing Spondylitis (AS)/ Behçet’s Disease Pipeline Drugs – Opportunity Assessments, Epidemiology Forecast, Market Dynamics, and Pipeline Analysis H2 2018. GervanoRA analyzed and assessed Ankylosing Spondylitis (AS)/ Behçet’s Disease pipeline molecules for the opportunities in the competitive space by covering all the pipeline molecules in